Protecting Seniors Access to Proper Care Act of 2017
This bill allows an authorized physician or practitioner who is not enrolled as a Medicare provider to, under certain circumstances, prescribe covered drugs under the Medicare prescription drug benefit. Specifically, the bill applies to a physician or practitioner, other than a doctor of medicine or osteopathy, who: (1) is not otherwise barred or excluded from participating in Medicare, and (2) prescribes a low-volume of billings for such drugs.
[Congressional Bills 115th Congress]
[From the U.S. Government Publishing Office]
[H.R. 4169 Introduced in House (IH)]
<DOC>
115th CONGRESS
1st Session
H. R. 4169
To amend title XVIII of the Social Security Act to remove the
enrollment restriction on certain physicians and practitioners
prescribing covered outpatient drugs under the Medicare prescription
drug program.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
October 31, 2017
Mr. Marchant (for himself, Mr. Smith of Missouri, Mr. Simpson, and Mr.
Ferguson) introduced the following bill; which was referred to the
Committee on Energy and Commerce, and in addition to the Committee on
Ways and Means, for a period to be subsequently determined by the
Speaker, in each case for consideration of such provisions as fall
within the jurisdiction of the committee concerned
_______________________________________________________________________
A BILL
To amend title XVIII of the Social Security Act to remove the
enrollment restriction on certain physicians and practitioners
prescribing covered outpatient drugs under the Medicare prescription
drug program.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ``Protecting Seniors Access to Proper
Care Act of 2017''.
SEC. 2. PERMITTING CERTAIN NON-ENROLLED PHYSICIANS OR PRACTITIONERS TO
PRESCRIBE COVERED OUTPATIENT DRUGS UNDER MEDICARE PART D.
(a) In General.--Section 1860D-4 of the Social Security Act (42
U.S.C. 1395w-103) is amended by adding at the end the following new
subsection:
``(m) Removal of Enrollment Restriction.--
``(1) In general.--Nothing in this title or section 6405(c)
of the Patient Protection and Affordable Care Act shall be
construed as authorizing the Secretary to require, as a
condition of payment by a PDP sponsor for a covered part D drug
that is prescribed by an applicable physician or practitioner
who is authorized under State law to prescribe such drug, that
such applicable physician or practitioner be enrolled under
section 1866(j).
``(2) Applicable physician or practitioner defined.--For
purposes of paragraph (1), the term `applicable physician or
practitioner' means an eligible professional described in
section 1848(k)(3)(B) (other than a physician described in
section 1861(r)(1))--
``(A) who--
``(i) is not excluded under this title or
title XI;
``(ii) is not barred from participating in
the program under this title for a period of
time following a revocation under section
424.535(c) of title 42, Code of Federal
Regulations (or any successor regulation); or
``(iii) meets other criteria similar to
clauses (i) and (ii) that may be specified by
the Secretary; and
``(B) who prescribes a low volume (as determined by
the Secretary) of such drugs to individuals enrolled in
plans under this part.
In determining low volume under subparagraph (B), the Secretary
may determine low volume differently based on the specialty of
the applicable physician or practitioner.''.
(b) Effective Date and Enforcement Delay.--
(1) Effective date.--The amendment made by subsection (a)
shall apply to covered part D drugs prescribed on or after
January 1, 2019.
(2) Delay in enforcement of enrollment requirement until
low volume exemption is implemented.--The Secretary shall
continue not to enforce the enrollment requirement under
clauses (ii) through (v) of section 423.120(c)(6) of title 42,
Code of Federal Regulations, until section 1860D-4(m), as added
by subsection (a), takes effect.
<all>
Introduced in House
Introduced in House
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Subcommittee on Health.
Llama 3.2 · runs locally in your browser
Ask anything about this bill. The AI reads the full text to answer.
Enter to send · Shift+Enter for new line